“…It provides real-time information on atrioventricular size and function, valvular apparatus, and other cardiac structures and forms the first-line imaging modality for the evaluation of pregnant women with suspected CVDs (6). Echocardiography plays a key role in the differential diagnosis between PPCM and other pregnancy-related cardiac diseases such as preeclampsia (25), in which LV systolic function is mostly unaffected, valvular heart diseases (VHDs), and congenital heart diseases (CHDs), and enables long-term monitoring of cardiac function (26) ( Table 2). Although LV systolic dysfunction is observed in the vast majority of PPCM patients, as reduced LVEF is a major criterion for the diagnosis (5), several studies reported unexplained HF with preserved LVEF in peripartum women, suggesting the possibility of progressive myocardial disease development across different clinical stages (27)(28)(29) and raising the challenge for early diagnosis.…”